文献速递头颈外科

口咽癌患者基线认知评估:PROMIS与NIH Toolbox研究

Baseline Cognition Assessment Among Patients With Oropharyngeal Cancer Using PROMIS and NIH Toolbox.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2018-01-01

这项前瞻性队列研究在三级学术中心纳入56例新诊断口咽癌患者,采用PROMIS和NIH Toolbox认知量表评估基线认知。自评认知受损占11%,NIH Toolbox总认知客观受损占32%,智力分层认知受损占21%。客观认知受损在男性、p16阴性、中重度合并症及听力损失者中更常见。

要点

  • 口咽癌患者基线客观认知受损率高于自评认知受损率。
  • 男性、p16阴性、中重度合并症及听力损失者客观认知受损更常见。
  • NIH Toolbox可即时评分并识别人群调整后的认知功能。

核心结论

  • 口咽癌患者基线客观认知受损较自评更常见,且在男性、p16阴性、中重度合并症及听力损失者中更频繁。

研究设计与样本

  • 前瞻性队列研究,三级学术中心,2016年9月至2017年5月连续83例新诊断口咽癌患者,最终纳入56例。

主要发现

  • 56例中位年龄59岁(范围42-77岁),52例男性、4例女性。
  • 自评认知受损6例(11%),NIH Toolbox总认知受损18例(32%),智力分层认知受损12例(21%)。
  • 客观认知受损在男性中占23%而女性0%,p16阴性者33%而p16阳性者20%,中重度合并症者31%而无者18%,听力损失者31%而无者12%。

关键数值与推荐

  • PROMIS自评认知受损定义为T评分低于0.5 SD。
  • NIH Toolbox总认知受损定义为至少1个认知域T评分低于1.5 SD或2个及以上域低于1 SD。
  • NIH Toolbox智力分层认知受损按既往发表标准以T评分判定。

临床怎么用

  • 临床可用NIH Toolbox即时评分识别人群调整后的基线认知受损患者。
  • 基线认知受损者可能易在治疗后进一步受损,可据此早期启动认知干预以改善治疗后生活质量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Cognitive dysfunction (CD) is recognized by the American Cancer Society as a treatment effect in head and neck cancer, but the extent of this problem at baseline in oropharyngeal cancer (OPC), the most common subsite in current practice, to our knowledge has never been studied. OBJECTIVE: To assess the baseline cognition of patients with OPC using National Institutes of Health (NIH)-sponsored instruments of Patient-Reported Outcomes Measurement Information System (PROMIS) and NIH Toolbox Cognitive Battery (NIHTB-CB). DESIGN, SETTING, AND PARTICIPANTS: This was a prospective cohort study conducted at a tertiary academic center. Of 83 consecutive patients, newly diagnosed as having OPC from September 2016 to May 2017, 16 were ineligible, 8 refused to participate, and 3 were lost to follow-up after screening, resulting in 56 study participants. MAIN OUTCOMES AND MEASURES: Self-perceived and objective cognition with PROMIS and NIHTB-CB standardized T scores, respectively, were main outcomes. Impairment was defined as (1) T scores less than 0.5 SD for PROMIS; (2) T score less than 1.5 SD in at least 1 cognitive domain or less than 1 SD in 2 or more domains for NIHTB-CB total cognition; and (3) T score per previously published criteria for NIHTB-CB intelligence-stratified cognition. RESULTS: Of the 56 study participants (52 men, 4 women; median age, 59 years [range, 42-77 years]), 19 (34%) had a college degree, and 20 (36%) had a professional or technical occupation. Thirty (about 53%) were never-smokers, 26 (46%) were never-drinkers, 29 (52%) were obese, 13 (23%) had a moderate to severe comorbidity, 3 (5%) used antidepressants, and 25 (52%) had hearing loss. Impaired self-reported, NIHTB-CB total, and intelligence-stratified cognition scores were observed in 6 (11%), 18 (32%), and 12 (21%), respectively. Among all variables, objective impairment was more common in men (23% vs 0%) and those with p16-negative OPC (33% vs 20%), moderate to severe comorbidity (31% vs 18%), and hearing loss (31% vs 12%). CONCLUSIONS AND RELEVANCE: Impaired objective cognition was more common at baseline than self-reported, and was more frequent in men, participants with p16-negative OPC, moderate to severe comorbidity, and hearing loss. NIHTB-CB allowed immediate scoring of demographically adjusted cognitive function. In clinical practice, these scores can be used to identify patients with impaired cognition at baseline who may be susceptible to developing further impairment after treatment. Identification of impairment at baseline will help to institute early cognitive interventions, which may lead to an improved posttreatment quality of life.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Sinha P, Wong AWK, Kallogjeri D, et al. Baseline Cognition Assessment Among Patients With Oropharyngeal Cancer Using PROMIS and NIH Toolbox. JAMA Otolaryngol Head Neck Surg. 2018. PMID: 29710116. doi:10.1001/jamaoto.2018.0283

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。